GSK announces regulatory submission for umeclidinium monotherapy for COPD in Japan
GSK announced the submission of a regulatory application to the Japanese MHLW for UMEC a LAMA, administered using the Ellipta™ dry powder inhaler.
Source: GSK news - Category: Pharmaceuticals Source Type: news
More News: Chronic Obstructive Pulmonary | Pharmaceuticals